Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Ruminant Biotech has launched a C$7.6m ($9.24m) research project to further validate its technology.
The Kiwi agtech company is developing a slow release bolus for cattle that can reduce methane emissions by more than 70% for up to six months.
The Canadian research programme – underpinned by a C$2.8m grant form the Government of Alberta – marks the company’s first international expansion beyond Australasia.
The research will generate the data needed to secure product registration and commercialisation in Canada, and establish the regulatory and data platform required to expand into the US, Brazil, and the EU.
To oversee the project, and support a broader Canadian and US expansion, Ruminant Biotech will establish a North American base in Calgary.
In November, Ruminant Biotech raised $17m in a Series A funding round to support a commercial launch this year, which was co-led by existing investors Rosrain Investments and US VC Cultivate Ventures.